top of page

156-158 PACIFIC HIGHWAY, GREENWICH, NSW 2065

(02) 8061 4048

Centre of Excellence

Research & Development

Sydney Brachytherapy Group participates in research and development at the University of NSW and contributes to OncoBeta’s International Skin Cancer Registry. Our visiting medical specialists are affiliated with Australian universities and engage in the education of specialist doctors, doctors in training and medical schools.

ANSTO.png
Print_logo_oncobeta_EN_with R_1812x423 -KO.png
Affiliations

Sydney Brachytherapy Group aligns with Vivascope for Confocal Reflectance Microscopy (RCM), Heine Optotechnik, Germany, for the Loupes/Dermatoscopy and Vivosight Germany for Optical Coherence Infrared Tomography (OTC).

VivoSight-Logo-with-strap-large-705x276.png
Heine2.png
Vivascope.png
Become an SBG Provider

As a tertiary referral medical facility, SBG can add a complimentary service to your current mainstay skin cancer treatment options. Find out how your practice can become affiliated and how you and your patients will benefit.

SBG Logo White+Green.png

ADDRESS

LEVEL 3, SUITE 304,

156-158 PACIFIC HIGHWAY
GREENWICH, NSW
Australia 2065

OPENING HOURS

Monday - Friday: 9:00am – 5:00pm

Treatment Enquiry

Please take a moment to fill out the form.

Thanks for submitting!

REFERENCES: 1. Castellucci P, et al. High dose brachytherapy with non sealed 188Re (rhenium) resin in patients with non-melanoma skin cancers (NMSCs): single center preliminary results. Eur J Nucl Med Mol Imaging. 2021;48(5):1511-1521. doi: 10.1007/s00259-020-05088-z. 2. Cipriani C, et al. Epidermal Radionuclide Therapy - Dermatological High-Dose-Rate. Brachytherapy for the Treatment of Basal and Squamous Cell Carcinoma. In: Therapeutic Nuclear Medicine, editor Baum RP; New York: Springer, 2014. 3. Cipriani C, et al. Personalized irradiation therapy for NMSC by rhenium-188 skin cancer therapy: a long-term retrospective study. J Dermatolog Treat. 2020:1-7. doi: 10.1080/09546634.2020.1793890. 4. Cipriani C, et al. Personalized high-dose-rate brachytherapy with non-sealed rhenium-188 in non-melanoma skin cancer. Int J Nucl Med. 2017;114–112. 5. Data on file. OncoBeta Garching, Germany.

Rhenium-SCT® and OncoBeta® is trademark of OncoBeta GmbH.

Copyright © 2022. Sydney Brachytherapy Group.

bottom of page